Targeted expression of human CuZn superoxide dismutase gene in mouse central nervous system

Journal of Neuroscience Methods

Volumn 89, Issue 1, 1999, Pages 49-55

  Li, Yibing ^a   Carlson, Elaine ^a   Murakami, Kensuke ^a   Copin, Jean Christophe ^a,b   Luche, Ralph ^a   Chen, Sylvia F ^a   Epstein, Charles J ^a   Chan, Pak H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Central nervous system; Copper zinc superoxide dismutase; Neuron specific enolase promoter; Purkinje cells; Reactive oxygen species; Transgenic mouse

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; NEURON SPECIFIC ENOLASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ANIMALS; BRAIN; BRAIN STEM; CEREBELLUM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; MALE; MICE; MICE, TRANSGENIC; NEURONS; PHOSPHOPYRUVATE HYDRATASE; PROMOTER REGIONS (GENETICS); PURKINJE CELLS; RATS; RECOMBINANT FUSION PROTEINS; RESTRICTION MAPPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE;

EID: 0032796043     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(99)00037-0     Document Type: Article

References (25)

1. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 38:1995;357-366.
2. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 18:1997;327-338.
3. Ceballos-Picot I., Nicole A., Briand P., Grimber G., Delacourte A., Defossez A., Javoy-Agid F., Lafon M., Blouin J.L., Sinet P.M. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome. Brain Res. 552:1991;198-214.
4. Chan P.H. Role of oxidants in ischemic brain damage. Stroke. 27:1996;1124-1129.
5. Chan P.H., Kawase M., Murakami K., Chen S.F., Li Y., Calagui B., Reola L., Carlson E., Epstein C.J. Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J Neurosci. 18:1998;8292-8299.
6. Copin J.-C., Reola L.F., Chan T.Y., Li Y., Epstein C.J., Chan P.H. Oxygen deprivation but not a combination of oxygen, glucose, and serum deprivation induces DNA degradation in mouse cortical neurons in vitro: attenuation by transgenic overexpression of CuZn-superoxide dismutase. J Neurotrauma. 13:1996;233-244.
7. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P. et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 261:1993;1047-1051.
8. Elroy-Stein O., Bernstein Y., Groner Y. Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation. EMBO J. 5:1986;615-622.
9. Epstein C.J., Avraham K.B., Lovett M., Smith S., Elroy-Stein O., Rotman G., Bry C., Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci USA. 84:1987;8044-8048.
10. Fattori E., Lazzaro D., Musiani P., Modesti A., Alonzi T., Ciliberto G. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur J Neurosci. 7:1995;2441-2449.
11. Forss-Petter S., Danielson P.E., Catsicas S., Battenberg E., Price J., Nerenberg M., Sutcliffe J.G. Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron. 5:1990;187-197.
12. Fukuda K., Aihara N., Sagar S.M., Sharp F.R., Pitts L.H., Honkaniemi J., Noble L.J. Purkinje cell vulnerability to mild traumatic brain injury. J Neurotrauma. 13:1996;255-266.
13. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X. et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 264:1994;1772-1775. [published erratum appears in Science 1995;269:149].
14. Kinouchi H., Epstein C.J., Mizui T., Carlson E., Chen S.F., Chan P.H. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci USA. 88:1991;11158-11162.
15. Kubisch H.M., Wang J., Luche R., Carlson E., Bray T.M., Epstein C.J., Phillips J.P. Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes. Proc Natl Acad Sci USA. 91:1994;9956-9959.
16. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C., Epstein C.J. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet. 11:1995;376-381.
17. Martinou J.C., Dubois-Dauphin M., Staple J.K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C. et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 13:1994;1017-1030.
18. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 244:1969;6049-6055.
19. Mellon P.L., Windle J.J., Goldsmith P.C., Padula C.A., Roberts J.L., Weiner R.I. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron. 5:1990;1-10.
20. Mikawa S., Kinouchi H., Kamii H., Gobbel G.T., Chen S.F., Carlson E., Epstein C.J., Chan P.H. Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice. J Neurosurg. 85:1996;885-891.
21. Ripps M.E., Huntley G.W., Hof P.R., Morrison J.H., Gordon J.W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 92:1995;689-693.
22. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62. [published erratum appears in Nature 1993;364:362].
23. Sakimura K., Kushiya E., Ogura A., Kudo Y., Katagiri T., Takahashi Y. Upstream and intron regulatory regions for expression of the rat neuron-specific enolase gene. Mol Brain Res. 28:1995;19-28.
24. Simonian N.A., Coyle J.T. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol. 36:1996;83-106.
25. Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 14:1995;1105-1116.